BioSpace News Archive

Business

Pfizer Reports Strong Third-quarter 2022 Results and Raises 2022 Outlook

Pfizer Inc. reported solid financial results for third-quarter 2022 and updated certain components of 2022 financial guidance.

November 1, 2022
·
65 min read
Business

Waters Corporation (NYSE: WAT) Reports Third Quarter 2022 Financial Results

Waters Corporation announced its financial results for the third quarter of 2022.

November 1, 2022
·
24 min read
Business

atai Life Sciences to Announce Third Quarter 2022 Financial Results and Business Update

atai Life Sciences N.V. (Nasdaq: ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, plans to announce its third quarter 2022 financial results and business update on Thursday, November 10, 2022.

November 1, 2022
·
1 min read
Deals

Citeline and Norstella Complete Merger to Form a $5 Billion Global Pharmaceutical Technology Company

Norstella , a global leader with end-to-end solutions that smooth access to life-saving therapies for patients, has announced the completion of its merger with Citeline a leader in the clinical trial intelligence space.

November 1, 2022
·
4 min read
Business

Intercept Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Update

Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced its financial results for the quarter ended September 30, 2022.

November 1, 2022
·
30 min read
Business

Veeva and Merck Form Long-Term Strategic Partnership

Veeva Systems (NYSE: VEEV) today announced a ten-year strategic partnership agreement with Merck.

November 1, 2022
·
3 min read
BioForest

Receptor Life Sciences Opens Second Investigational New Drug (IND) Application with FDA for RLS103 (Inhaled Dry Powder CBD) for the Treatment of Rapid Epileptic Seizure Termination (REST)

Receptor Life Sciences is expanding the potential clinical utility of RLS103 into epilepsy.

November 1, 2022
·
2 min read
Genetown

PureTech to Present at the Credit Suisse 31st Annual Healthcare Conference

PureTech Health plc today announced that Bharatt Chowrira, Ph.D., J.D., and Julie Krop, M.D., Chief Medical Officer, will participate in a fireside chat at the Credit Suisse 31st Annual Healthcare Conference in Rancho Palos Verdes, CA, on Tuesday, November 8, 2022, at 12:50pm PST / 3:50pm EST.

November 1, 2022
·
3 min read
Biotech Bay

Adicet Bio to Present at the 2022 Jefferies London Healthcare Conference

Adicet Bio, Inc. today announced that Chen Schor, President and Chief Executive Officer, will present at the 2022 Jefferies London Healthcare Conference being held from November 15-17, 2022 in London.

November 1, 2022
·
1 min read
Business

iA Enhances Executive Leadership Team and Appoints President and COO

iA, a provider of software-enabled pharmacy fulfillment and automation solutions, announced today several executive leadership team changes.

November 1, 2022
·
5 min read